Skip to Content
Merck

Key Documents

View All Documentation

EHU093861

MISSION® esiRNA

targeting human PIP4K2C

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GCAGAGAATTGGATTGGGTCTCTGTCATAGATTGAGTAATCTCTTCCCTTACCTCAATTCCATCTCCACCCATCTCTACATCTGGGCACAGCAACCCAGAGATGGCCAAAAGCATTCAAGCCTGGGGGAAGATGTTTGACTATTGCTGCTCTTCACCAGAACCTCACACCTCTCCTGGGACTGGAACCCTTCAGTGGGTGTGTGGCCAGTTTTGGAGGCTGGAATGATGGGCCAGGGTGTAGGATTCATTCTCCATGTAAAGTTTCCTTTCATCCTGCCTAGCCATCCCCAAGGTTTATTTCCAGAAGAAAGGAATATCTCTACTTGGATCAATTCTGGTCATTTCAAGAGGATGGAGGCCTCAAGTGTGGGAACTTCCCCTACTCCCTGGATGTGTGTACCTAGCACACTTCCTTCTCCCAC

Ensembl | human accession no.

ENSG00000166908

NCBI accession no.

NM_024779

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... PIP4K2C(79837)

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
JUU
NRR
RPR

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gaurav Sharma et al.
Autophagy, 15(10), 1694-1718 (2019-02-27)
High-throughput screening identified 5 chemical analogs (termed the WX8-family) that disrupted 3 events in lysosome homeostasis: (1) lysosome fission via tubulation without preventing homotypic lysosome fusion; (2) trafficking of molecules into lysosomes without altering lysosomal acidity, and (3) heterotypic fusion